Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02969590 · ClinicalTrials.gov registry record · Phase 4
Regulation of Cervical Mucus Secretion
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT02969590 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 5 participants.
The verdict
NCT02969590, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to help us determine how hormones impact the production of cervical mucus which is a fluid secreted by the opening of the uterus, also called the cervix. During a normal menstrual cycle, cervical mucus changes in response to two hormones that the ovaries make: estrogen and progesterone. Many of the birth control methods women use thicken mucus and make it less likely for sperm to enter the uterus. The goal of this study is to better understand the effects estrogen and progesterone have on the cervical mucus in the body. To do this, the investigators will be using a drug that suppresses natural hormone production for 3 months. Estrogen and progesterone will be artificially replaced to better understand their effects. The investigators will also be studying the effect of a common birth control pill that may work by thickening cervical mucus. Last, the investigators will study some of the cells in the cervix that produce mucus.
Interventions
- DRUG Leuprolide acetate
- DRUG Progestin
- DRUG Estrogen and Progesterone Replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-03-29 |
| Est. Completion | 2017-08-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02969590
The ClinicalTrials.gov registry entry for NCT02969590 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Leuprolide acetate is the first listed.
NCT02969590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02969590 about?
NCT02969590 is a clinical study titled "Regulation of Cervical Mucus Secretion". The purpose of this study is to help us determine how hormones impact the production of cervical mucus which is a fluid secreted by the opening of the uterus, also called the cervix. During a normal menstrual cycle, cervical mucus changes in response to two hormones that the ovaries make: estrogen a...
What is the current status of trial NCT02969590?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2015-03-29. Estimated completion is 2017-08-23.
What interventions are being tested in trial NCT02969590?
The interventions under investigation include: Leuprolide acetate (DRUG), Progestin (DRUG), Estrogen and Progesterone Replacement (DRUG).
Who is sponsoring clinical trial NCT02969590?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.